Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Clearing Lungs With Epithelial Sodium Channel (ENaC) Inhibition in Cystic Fibrosis (CF)

ClinicalTrials.gov ID: NCT02343445

Public ClinicalTrials.gov record NCT02343445. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 11:00 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of the study is to evaluate the safety and tolerability of P-1037 and to determine whether the combination of P-1037 with hypertonic saline or P-1037 alone has a greater effect on lung function in patients with CF than placebo (0.17% saline).

Study identification

NCT ID
NCT02343445
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Parion Sciences
Industry
Enrollment
142 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2015 (Type not available)
Primary completion
Feb 2016 (Actual)
Completion
Feb 2016 (Actual)
Last update posted
Jul 26, 2021

2015 – 2016

United States locations

U.S. sites
33
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
Children's Hospital of Los Angeles Los Angeles California 90027 —
Univ of Florida Dept of Medicine Gainesville Florida 32610 —
University of Miami Adult CF Center Miami Florida 33136 —
Central Florida Pulmonary Group, PA Orlando Florida 32803 —
New Lung Associates Tampa Florida 33606 —
Chicago Cystic Fibrosis Institute Glenview Illinois 60025 —
University of Kansas Medical Center Kansas City Kansas 66160 —
Tulane University Health Sciences Center New Orleans Louisiana 70112 —
Maine Medical Center Portland Maine 04102 —
Johns Hopkins University Baltimore Maryland 21287 —
UMass Memorial medical Center Worcester Massachusetts 01655 —
Wayne State University/Harper University Hospital Detroit Michigan 48201 —
Washington University St Louis Missouri 63110 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Rutgets-Robert Wood Johnson Medical School New Brunswick New Jersey 08901 —
Pediatric Pulmonology/Cystic Fibrosis Somerville New Jersey 08876 —
Albany Medical College Albany New York 12208 —
Long Island Jewish Medical Center New Hyde Park New York 11042 —
University of North Carolina Chapel Hill North Carolina 27517 —
Clinical Research of Charlotte Charlotte North Carolina 28277 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Toledo Hospital Toledo Ohio 43606 —
Santiago Reyes Oklahoma City Oklahoma 73112 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Anderson Pharmaceutical Research Anderson South Carolina 29621 —
Medical University of South Carolina Charleston South Carolina 29425 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
Austin Children's Chest Associates Austin Texas 78723 —
UT Southwestern Medical Center Dallas Texas 75390 —
Alamo Clinical Research Associates San Antonio Texas 78212 —
Univ of Texas Health Science Center Tyler Texas 75708 —
University of Virginia Childrens Charlottesville Virginia 22908 —
University of Wisconsin UW Hospital Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02343445, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2021 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02343445 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →